Commodore Capital »

Avalo Therapeutics Ord shares owned by Commodore Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $499k 40k 12.47

More positions owned by Commodore Capital

Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Soleno Therapeutics (SLNO)
Celldex Therapeutics Com New (CLDX)
Mind Medicine Mindmed Com New (MNMD)
Rhythm Pharmaceuticals (RYTM)
Arvinas Ord (ARVN)
Spyre Therapeutics Com New (SYRE)
Perspective Therapeutics Com New (CATX)
Pharvaris N V (PHVS)

View all positions for Commodore Capital

Top funds holding Avalo Therapeutics Ord

Logos Global Management
Sio Capital Management
Ikarian Capital
Affinity Asset Advisors
Commodore Capital
Vanguard Group
Bank of America Corporation
Royal Bank of Canada
Banque Cantonale Vaudoise
BlackRock
Morgan Stanley
Efficient Wealth Management
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co

View all funds holding Avalo Therapeutics Ord